Seven-time Tour de France champion to raise funds for CBCF's cancer research initiatives

Cancer survivor and seven-time Tour de France champion, Lance Armstrong, will be in Calgary September 8 to support the work of the Canadian Breast Cancer Foundation (CBCF) - Prairies/NWT Region during the Foundation's 25th anniversary.

As part of LinkPink 2011, Lance will lead a fundraising group of individual and team cyclists on a 60 km ride in the morning. Later that day, he will deliver an inspiring message about cancer and participate in a question and answer session moderated by legendary cycling commentator Phil Liggett during a dinner at the Calgary TELUS Convention Centre.

"I am honored to return to Calgary in September to not only help the Canadian Breast Cancer Foundation celebrate their 25th anniversary, but raise important funds for their cancer research initiatives," says Armstrong.

"We are so proud to announce Lance Armstrong's involvement again with the Foundation, and we are incredibly appreciative of his support," says CBCF-Prairies/NWT Region CEO, Trish Bronsch. "To have arguably one of the most well known and influential cancer advocates in the world visit Calgary as a supporter of the CBCF is truly an honour."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
History of endometriosis and fibroids linked to higher long-term risk of early death